BCS
Barclays plc ADR
$22.82-3.71%
Setup
No setup
Buy Zone
$23.7-$24.89
Sector
Banks - Diversified
Industry
Banks - Diversified
36
Recommendation
Avoid
Avoid
Too many CANSLIM criteria failing.
BCS chart
Loading chart…
ADX
Developing24.0Long Term
Up ↑Intermediate Term
Up ↑Short Term
Up ↑Overall Quality36
RS Rating
45
relative strength
Fundamentals
66
Solid fund-Q
Volume Demand
68
+117% vs avg
Technical Setup
38
3/8 checks
Industry/Theme
91
Banks - Diversified
Trade Plan
Avoid
Entry
$23.7
Entry Zone
$23.7-$24.89
Stop / Risk
$21.8
RS Rating
45
Volume confirmed
No
Targets
$28.44 / $29.63
Breakout · IBD Setup
1 ✓ 7 ✗
Entry $23.7–$24.89Stop $21.8Target $28.44 / $29.63
Market regimeRange
Quality36
RS Rating45
Above 50-MA-5.74%
Above 200-MA-7.99%
VolumeWeak
In Buy ZoneNo
Not extendedOK
Invalidation · Close below stop
How this came together
36
MarketRange
SetupNo setup
ConfidenceExperimental · not backtested
Fund-Q66 · Solid
StatusAvoid
Stock Data
52-Week Range20 – 29
Price % Chg YTD-10.33%
Price % Chg 4wk-0.78%
50-Day Avg Vol4.7 Mil
P/E Ratio7.9
Market Cap$74B
SectorFinancial
IndustryBanks - Diversified
Company Fundamentals
EPS % Chg (Qtr)17.78%
Sales % Chg (Qtr)2.41%
EPS Growth 5y38.51%
Sales Growth 5y15.25%
Annual ROE11.11%
Gross Margin—
Operating Margin33.53%
Net Margin22.74%
Debt / Equity2.95
Setup levels
Current price
$22.82
Pivot
$23.7
Distance to buy
-20.4%
52-week range
19.83-28.69
Trigger evidence
No active trigger evidence available.
Financial health checks
3/5
Return on equity above 15%
ROE 11.11%
Net margin above 10%
Net margin 22.74%
EPS growing quarter on quarter
EPS q/q 17.78%
Sales growing quarter on quarter
Sales q/q 2.41%
Debt to equity below 1.0
D/E 2.95
Key metrics
Finviz snapshot · value vs. sector median (≥5 peers)
Annual ROE11.11%
vs sector -4.2%
Net margin22.74%
vs sector +2.6%
Gross margin—
EPS growth q/q17.78%
vs sector +0.6%
Sales growth q/q2.41%
vs sector -4.2%
Debt / equity2.95
vs sector +0.20
Business quality
66
GradeSolid
EPS rating59
P/E7.9
Market cap$74B
IndustryBanks - Diversified
Technical checks
Über 50-MA
Fail
Über 200-MA
Fail
RS-Linie auf neuem Hoch
Fail
Volumen bestätigt
Fail
In Kaufzone
Fail
Nicht überextended
Pass
Über 21-EMA
Pass
Volumen gesund
Pass
IBD / source mentions
No recent IBD mention found for this ticker.
Signal history
Added to list
2026-11-04
Trigger date
—
Days on list
2
Data sources: internal CANSLIM engine · Finviz snapshot · TradingView chart. Not investment advice.